Dermatology OTC Medications Market Forecast to 2028

Report Code : TIPRE00010460 | Region : Global | Industry : Pharmaceuticals | Published Date : 15/Mar/2022
Dermatology OTC Medications Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Tablets and Capsules, Gels, Creams and Ointments, and Others), Route of Administration (Topical and Oral), Indication (Dermatitis, Acne, Psoriasis, Skin Bleaching, Fungal Disease, Warts, and Others), and Distribution Channel (Online Distribution and Offline Distribution)

The dermatology OTC medications market is expected to grow from US$ 15,456.63 million in 2021 to US$ 21,313.40 million by 2028; it is estimated to grow at a CAGR of 4.7% from 2021 to 2028.

The high prevalence of skin problems and rising income of middle-class population are expected to boost the global market growth. However, the inappropriate use of OTC medications is restraining the growth of market.

The COVID-19 pandemic has been adversely affecting several businesses across global. The supply chain disruptions and the huge demand for efficient treatments of COVID-19 have critically impacted the healthcare research industry in China. Prohibitive measures have been taken to resist the spread of the COVID-19 pandemic. The pandemic is expected to impact the dermatology OTC medications market significantly. For instance, India’s manufacturers rely heavily on imports of their APIs from China. The lockdown has slowed the production of APIs, resulting in less availability and higher costs for the materials required for the products. Owing to the high demand for essential OTC drugs, the government has restricted the export of a few essential medicines. Due to the countrywide lockdown, the traditional supply chain of OTC drugs is facing several challenges. Many of these drugs are not available. Even after the specific guidelines and support of the state government to transport the essential OTC drugs, many retail pharmacies are experiencing a shortage of stock. On the other hand, the online purchase of OTC drugs has increased.

Most of the population agreed that fear of contracting SARS-CoV-2 would be a standalone factor for not undergoing any skin disease treatment during the COVID-19 pandemic in the country. This has resulted in a drastic drop in demand for dermatological treatment. On the other hand, a cross-sectional study conducted by Al Saud et al., published in Plastic and Reconstructive Surgery Global Open Journal, in September 2020, reveals that over two-thirds (~69.5%) of OTC dermatology drugs indicated that the COVID-19 pandemic had negatively affected practices in Saudi Arabia. For example, surgeons in private practices were affected more significantly than the public sector due to fear and future uncertainty, leading to surge in utilization of different technical means for maintaining such a high patient pool.

As per European Union, the middle-class population is expected to reach 5.3 billion by 2030, and the Asian population of middle-class people is likely to be at the forefront. According to the World Bank Group, by 2030, China and India are expected to represent ~66% of the global middle-class population and ~59% of middle-class consumption. With significant changes in consumer behavior and consumption patterns, the middle-class expansion will drive global economic development. In addition, the US Bureau of Labor Statistics stated that disposable income in the US increased from US$ 10,036.9 billion in 2006 to US$ 13,968.6 billion in 2016; it is further expected to reach US$ 21,178.2 billion by 2026. Increased disposable incomes and better after-care treatment have led to the growing adoption of dermatology OTC medications to treat skin conditions. Thus, a surge in the adoption rate of OTC medications supports the growth of the dermatology OTC medications market.

The approval is likely to enables the company to sell these products in the global dermatology OTC medications market. Similarly, the key companies are focusing on strategic initiatives such as mergers, acquisitions, new product development, and geographical expansions. For instance, in July 2016, Galderma received FDA approval for Differin Gel 0.1 percent (adapalene), a once-daily topical gel for the over-the-counter (OTC) treatment of acne, in July 2016. Differin Gel 0.1 percent is licensed for usage in people aged 12 and up.

The high prevalence of the skin disease support the growth of the dermatology OTC medications market. Acne affected 5.6 million Canadians, or ~20% of the population, according to the Canadian Dermatology Association in 2021. Similarly, ~80% of acne patients are aged between 12 and 24. Acne affects ~90% of teenagers and 20-30% of adults aged from 20 to 40. Similarly, as per a study published in the journal Actas Dermo-Sifiliográficas in 2019, the prevalence of psoriasis in France was 5.2% of the entire French population. Moreover, according to 2020 US census data, ~7.55 million US individuals are suffering from psoriasis. The prevalence of psoriasis was similar in men and women, with 3.2% in women and 2.8% in men.

The rising healthcare expenditure supports the growth of the dermatology OTC medications market during the forecast period. Pharmaceutical spending includes prescription medications and self-medication, also known as over-the-counter (OTC) items. In 2019, pharmaceutical products spending accounted for 14.3% and 11.9% of Germany's and France’s total healthcare expenditure, respectively.

Indication-Based Insights

The dermatology OTC medications market is segmented into product type, route of administration, indication, and distribution channel. Based on indication, the global market is segmented into dermatitis, acne, psoriasis, skin bleaching, fungal disease, warts, and others. The acne segment held the largest share of the dermatology OTC medications market in 2021; it is estimated to register the highest CAGR in the dermatology OTC medications market during the forecast period.

The Food and Drug Administration, the World Health Organization, the European Commission, the American Academy of Dermatology, the National Center for Biotechnology Information, the Canadian Skin Patient Alliance, the Skin Science Foundation, the European Society for Dermatological Research, the Economic Co-operation and Development, and the Canadian Dermatology Association are among the primary and secondary sources referred to while preparing the report on the dermatology OTC medications market.

List of Companies:

1. Bausch Health Companies Inc.

2. Perrigo Company plc

3. Bayer AG

4. Viatris Inc.

5. Johnson and Johnson Services, Inc.

6. LEO Pharma A/S

7. GlaxoSmithKline plc.

8. Galderma

9. Dr. Reddy's Laboratories

10. Acella Pharmaceuticals, LLC

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Dermatology OTC Medications Market – By Product Type

1.3.2 Global Dermatology OTC Medications Market – By Route of Administration

1.3.3 Global Dermatology OTC Medications Market – By Indication

1.3.4 Global Dermatology OTC Medications Market – By Distribution Channel

1.3.5 Global Dermatology OTC Medications Market – By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Dermatology OTC Medications Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East And Africa PEST Analysis

4.2.5 South & Central America PEST Analysis

4.3 Experts Opinion

5. Dermatology OTC Medications Market – Key Market Dynamics

5.1 Key Market Drivers

5.1.1 High Prevalence of Skin Problems

5.1.2 Rising Income of Middle-Class Population

5.2 Market Restraints

5.2.1 Inappropriate Use of OTC Medications

5.3 Market Opportunities

5.3.1 Growing OTC Market

5.4 Future Trends

5.4.1 Transition from Rx to OTC

5.5 Impact Analysis of Drivers and Restraints

6. Dermatology OTC Medications Market– Global Analysis

6.1 Global Dermatology OTC Medications Market Revenue Forecast and Analysis

6.2 Global Dermatology OTC Medications Market, By Geography - Forecast and Analysis

6.3 Market Positioning of Key Players

7. Dermatology OTC Medications Market Analysis – By Product Type

7.1 Overview

7.2 Dermatology OTC Medications Market Share by Product Type, 2021 & 2028 (%)

7.3 Tablets and Capsules

7.3.1 Overview

7.3.2 Tablets and Capsules Market Revenue and Forecast to 2028 (US$ million)

7.4 Gels

7.4.1 Overview

7.4.2 Gels Market Revenue and Forecast to 2028 (US$ million)

7.5 Creams and Ointments

7.5.1 Overview

7.5.2 Creams and Ointments Market Revenue and Forecast to 2028 (US$ million)

7.6 Others

7.6.1 Overview

7.6.2 Others Market Revenue and Forecast to 2028 (US$ million)

8. Dermatology OTC medications Market Analysis – By Route of Administration

8.1 Overview

8.2 Dermatology OTC Medications Market Share, by Route of Administration, 2021 and 2028 (%)

8.3 Topical

8.3.1 Overview

8.3.2 Topical: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

8.4 Oral

8.4.1 Overview

8.4.2 Oral: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9. Dermatology OTC Medications Market Analysis – By Indication

9.1 Overview

9.2 Dermatology OTC Medications Market Share, by Indication, 2021 and 2028 (%)

9.3 Dermatitis

9.3.1 Overview

9.3.2 Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.3.3 Atopic Dermatitis

9.3.3.1 Overview

9.3.3.2 Atopic Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.3.4 Contact Dermatitis

9.3.4.1 Overview

9.3.4.2 Contact Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.3.5 Others

9.3.5.1 Overview

9.3.5.2 Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.4 Acne

9.4.1 Overview

9.4.2 Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.4.3 Non-Inflammatory Acne

9.4.3.1 Overview

9.4.3.2 Non-Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.4.4 Inflammatory Acne

9.4.4.1 Overview

9.4.4.2 Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5 Psoriasis

9.5.1 Overview

9.5.2 Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5.3 Plaque Psoriasis

9.5.3.1 Overview

9.5.3.2 Plaque Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5.4 Guttate Psoriasis

9.5.4.1 Overview

9.5.4.2 Guttate Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5.5 Others

9.5.5.1 Overview

9.5.5.2 Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.6 Skin Bleaching

9.6.1 Overview

9.6.2 Skin Bleaching: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7 Fungal Disease

9.7.1 Overview

9.7.2 Fungal Disease: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.3 Athlete's Foot

9.7.3.1 Overview

9.7.3.2 Athlete's Foot: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.4 Ringworm

9.7.4.1 Overview

9.7.4.2 Ringworm: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.5 Fungal Nail Infections

9.7.5.1 Overview

9.7.5.2 Fungal Nail Infections: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.6 Others

9.7.6.1 Overview

9.7.6.2 Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8 Warts

9.8.1 Overview

9.8.2 Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8.3 Common Warts

9.8.3.1 Overview

9.8.3.2 Common Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8.4 Flat Warts

9.8.4.1 Overview

9.8.4.2 Flat Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8.5 Others

9.8.5.1 Overview

9.8.5.2 Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.9 Others

9.9.1 Overview

9.9.2 Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10. Dermatology OTC medications Market Analysis – By Distribution Channel

10.1 Overview

10.2 Dermatology OTC Medications Market Share, by Distribution Channel, 2021 and 2028 (%)

10.3 Online Distribution

10.3.1 Overview

10.3.2 Online Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.4 Offline Distribution

10.4.1 Overview

10.4.2 Offline Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.4.3 Retail and Hospital Pharmacies

10.4.3.1 Overview

10.4.3.2 Retail and Hospital Pharmacies: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.4.4 Super and Hyper Markets

10.4.4.1 Overview

10.4.4.2 Super and Hyper Markets: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

11. Dermatology OTC Medications Market Revenue and Forecasts to 2028 – Geographical Analysis

11.1 North America Dermatology OTC Medications Market Revenue and Forecasts To 2028

11.1.1 Overview

11.1.2 North America: Dermatology OTC Medications – Revenue and Forecast to 2028 (USD Million)

11.1.3 North America: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.4 North America: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.1.5 North America: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.1.5.1 North America: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.1.5.2 North America: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.1.5.3 North America: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.1.5.4 North America: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.1.5.5 North America: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.1.6 North America: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.6.1 North America: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.1.7 North America Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)

11.1.8 US: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.8.1 Overview

11.1.8.2 US: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.8.3 US: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.8.4 US: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.1.8.5 US: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.1.8.5.1 US: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.1.8.5.2 US: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.1.8.5.3 US: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.1.8.5.4 US: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.1.8.5.5 US: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.1.8.6 US: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.8.6.1 US: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.1.9 Canada: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.9.1 Overview

11.1.9.2 Canada: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.9.3 Canada: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.9.4 Canada: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.1.9.5 Canada: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.1.9.5.1 Canada: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.1.9.5.2 Canada: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.1.9.5.3 Canada: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.1.9.5.4 Canada: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.1.9.5.5 Canada: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.1.9.6 Canada: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.9.6.1 Canada: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.1.10 Mexico: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.10.1 Overview

11.1.10.2 Mexico: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.10.3 Mexico: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.10.4 Mexico: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.1.10.5 Mexico: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.1.10.5.1 Mexico: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.1.10.5.2 Mexico: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.1.10.5.3 Mexico: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.1.10.5.4 Mexico: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.1.10.5.5 Mexico: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.1.10.6 Mexico: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.10.6.1 Mexico: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.2 Europe Dermatology OTC Medications Market Revenue and Forecasts To 2028

11.2.1 Overview

11.2.2 Europe: Dermatology OTC Medications – Revenue and Forecast to 2028 (USD Million)

11.2.3 Europe: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.2.4 Europe: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.2.5 Europe: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.2.5.1 Europe: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.2.5.2 Europe: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.2.5.3 Europe: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.2.5.4 Europe: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.2.5.5 Europe: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.2.6 Europe: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.2.6.1 Europe: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.2.7 Europe: Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)

11.2.8 Germany: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.2.8.1 Overview

11.2.8.2 Germany: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.2.8.3 Germany: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.2.8.4 Germany: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.2.8.5 Germany: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.2.8.5.1 Germany: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.2.8.5.2 Germany: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.2.8.5.3 Germany: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.2.8.5.4 Germany: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.2.8.5.5 Germany: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.2.8.6 Germany: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.2.8.6.1 Germany: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.2.9 France: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.2.9.1 Overview

11.2.9.2 France: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.2.9.3 France: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.2.9.4 France: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.2.9.5 France: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.2.9.5.1 France: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.2.9.5.2 France: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.2.9.5.3 France: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.2.9.5.4 France: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.2.9.5.5 France: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.2.9.6 France: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.2.9.6.1 France: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.2.10 UK: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.2.10.1 Overview

11.2.10.2 UK: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.2.10.3 UK: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.2.10.4 UK: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.2.10.5 UK: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.2.10.5.1 UK: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.2.10.5.2 UK: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.2.10.5.3 UK: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.2.10.5.4 UK: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.2.10.5.5 UK: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.2.10.6 UK: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.2.10.6.1 UK: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.2.11 Italy: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.2.11.1 Overview

11.2.11.2 Italy: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.2.11.3 Italy: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.2.11.4 Italy: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.2.11.5 Italy: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.2.11.5.1 Italy: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.2.11.5.2 Italy: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.2.11.5.3 Italy: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.2.11.5.4 Italy: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.2.11.5.5 Italy: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.2.11.6 Italy: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.2.11.6.1 Italy: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.2.12 Spain: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.2.12.1 Overview

11.2.12.2 Spain: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.2.12.3 Spain: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.2.12.4 Spain: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.2.12.5 Spain: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.2.12.5.1 Spain: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.2.12.5.2 Spain: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.2.12.5.3 Spain: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.2.12.5.4 Spain: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.2.12.5.5 Spain: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.2.12.6 Spain: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.2.12.6.1 Spain: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.2.13 Rest of Europe: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.2.13.1 Overview

11.2.13.2 Rest of Europe: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.2.13.3 Rest of Europe: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.2.13.4 Rest of Europe: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.2.13.5 Rest of Europe: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.2.13.5.1 Rest of Europe: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.2.13.5.2 Rest of Europe: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.2.13.5.3 Rest of Europe: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.2.13.5.4 Rest of Europe: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.2.13.5.5 Rest of Europe: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.2.13.6 Rest of Europe: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.2.13.6.1 Rest of Europe: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.3 Asia Pacific: Dermatology OTC Medications Market

11.3.1 Overview

11.3.2 Asia Pacific: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)

11.3.3 Asia Pacific: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.3.4 Asia Pacific: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.3.5 Asia Pacific: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.3.5.1 Asia Pacific: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.3.5.2 Asia Pacific: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.3.5.3 Asia Pacific: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.3.5.4 Asia Pacific: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.3.5.5 Asia Pacific: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.3.6 Asia Pacific: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.3.6.1 Asia Pacific: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.3.7 Asia Pacific: Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)

11.3.8 China: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.3.8.1 China: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.3.8.2 China: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.3.8.3 China: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.3.8.4 China: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.3.8.4.1 China: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.3.8.4.2 China: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.3.8.4.3 China: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.3.8.4.4 China: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.3.8.4.5 China: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.3.8.5 China: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.3.8.5.1 China: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.3.9 Japan: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.3.9.1 Japan: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.3.9.2 Japan: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.3.9.3 Japan: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.3.9.4 Japan: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.3.9.4.1 Japan: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.3.9.4.2 Japan: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.3.9.4.3 Japan: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.3.9.4.4 Japan: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.3.9.4.5 Japan: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.3.9.5 Japan: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.3.9.5.1 Japan: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.3.10 India: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.3.10.1 India: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.3.10.2 India: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.3.10.3 India: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.3.10.3.1 India: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.3.10.3.2 India: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.3.10.3.3 India: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.3.10.3.4 India: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.3.10.3.5 India: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.3.10.3.6 India: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.3.10.4 India: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.3.10.4.1 India: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.3.11 Australia: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.3.11.1 Australia: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.3.11.2 Australia: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.3.11.3 Australia: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.3.11.4 Australia: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.3.11.4.1 Australia: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.3.11.4.2 Australia: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.3.11.4.3 Australia: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.3.11.4.4 Australia: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.3.11.4.5 Australia: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.3.11.5 Australia: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.3.11.5.1 Australia: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.3.12 South Korea: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.3.12.1 South Korea: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.3.12.2 South Korea: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.3.12.3 South Korea: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.3.12.4 South Korea: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.3.12.4.1 South Korea: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.3.12.4.2 South Korea: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.3.12.4.3 South Korea: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.3.12.4.4 South Korea: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.3.12.4.5 South Korea: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.3.12.5 South Korea: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.3.12.5.1 South Korea: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.3.13 Rest of Asia Pacific: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.3.13.1 Rest of Asia Pacific: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.3.13.2 Rest of Asia Pacific: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.3.13.3 Rest of Asia Pacific: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.3.13.4 Rest of Asia Pacific: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.3.13.4.1 Rest of Asia Pacific: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.3.13.4.2 Rest of Asia Pacific: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.3.13.4.3 Rest of Asia Pacific: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

LIST OF TABLES.

Table 1. North America: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 2. North America: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 3. North America: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 4. North America: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 5. North America: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 6. North America: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 7. North America: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 8. North America: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 9. North America: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 10. North America: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 11. US: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 12. US: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 13. US: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 14. US: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 15. US: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 16. US: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 17. US: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 18. US: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 19. US: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 20. US: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 21. Canada: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 22. Canada: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 23. Canada: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 24. Canada: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 25. Canada: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 26. Canada: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 27. Canada: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 28. Canada: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 29. Canada: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 30. Canada: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 31. Mexico: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 32. Mexico: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 33. Mexico: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 34. Mexico: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 35. Mexico: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 36. Mexico: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 37. Mexico: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 38. Mexico: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 39. Mexico: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 40. Mexico: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 41. Europe: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 42. Europe: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 43. Europe: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 44. Europe: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 45. Europe: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 46. Europe: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 47. Europe: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 48. Europe: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 49. Europe: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 50. Europe: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 51. Germany: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 52. Germany: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 53. Germany: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 54. Germany: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 55. Germany: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 56. Germany: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 57. Germany: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 58. Germany: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 59. Germany: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 60. Germany: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 61. France: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 62. France: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 63. France: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 64. France: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 65. France: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 66. France: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 67. France: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 68. France: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 69. France: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 70. France: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 71. UK: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 72. UK: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 73. UK: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 74. UK: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 75. UK: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 76. UK: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 77. UK: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 78. UK: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 79. UK: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 80. UK: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 81. Italy: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 82. Italy: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 83. Italy: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 84. Italy: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 85. Italy: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 86. Italy: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 87. Italy: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 88. Italy: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 89. Italy: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 90. Italy: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 91. Spain: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 92. Spain: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 93. Spain: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 94. Spain: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 95. Spain: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 96. Spain: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 97. Spain: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 98. Spain: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 99. Spain: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 100. Spain: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 101. Rest of Europe: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 102. Rest of Europe: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 103. Rest of Europe: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 104. Rest of Europe: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 105. Rest of Europe: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 106. Rest of Europe: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 107. Rest of Europe: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 108. Rest of Europe: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 109. Rest of Europe: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 110. Rest of Europe: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 111. Asia Pacific: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 112. Asia Pacific: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 113. Asia Pacific: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 114. Asia Pacific: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 115. Asia Pacific: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 116. Asia Pacific: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 117. Asia Pacific: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 118. Asia Pacific: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 119. Asia Pacific: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 120. Asia Pacific: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 121. China: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 122. China: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 123. China: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 124. China: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 125. China: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 126. China: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 127. China: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 128. China: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 129. China: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 130. China: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 131. Japan: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 132. Japan: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 133. Japan: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 134. Japan: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 135. Japan: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 136. Japan: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 137. Japan: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 138. Japan: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 139. Japan: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 140. Japan: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 141. India: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 142. India: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 143. India: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 144. India: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 145. India: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 146. India: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 147. India: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 148. India: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 149. India: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 150. India: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 151. Australia: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 152. Australia: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 153. Australia: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 154. Australia: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 155. Australia: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 156. Australia: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 157. Australia: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 158. Australia: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 159. Australia: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 160. Australia: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 161. South Korea: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 162. South Korea: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 163. South Korea: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 164. South Korea: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 165. South Korea: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 166. South Korea: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 167. South Korea: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 168. South Korea: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 169. South Korea: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

List of Companies:

1. Bausch Health Companies Inc.

2. Perrigo Company plc

3. Bayer AG

4. Viatris Inc.

5. Johnson and Johnson Services, Inc.

6. LEO Pharma A/S

7. GlaxoSmithKline plc.

8. Galderma

9. Dr. Reddy's Laboratories

10. Acella Pharmaceuticals, LLC

Reason To Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global dermatology OTC medications market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the global dermatology OTC medications market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Dermatology OTC Medications Market Forecast to 2028 )
  • Single User Price $4,550$3,640
  • Site Price $6,550$5,240
  • Enterprise Price $8,550$6,840
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry